RESEARCH NOTICE & LEGAL DISCLAIMER

FOR RESEARCH PURPOSES ONLY. All information provided within the Biolabs Peptides Research Centre is intended strictly for scientific, laboratory, and educational purposes.

Not Medical Advice: The protocols and data presented herein do not constitute medical advice, nursing advice, or a professional healthcare diagnosis.
Non-Therapeutic: These peptides are not intended to diagnose, treat, cure, or prevent any medical condition or disease.
Researcher Responsibility: Any research conducted should be performed by qualified professionals in a controlled laboratory environment. By accessing this data, you acknowledge that you are responsible for following your local laws and institutional safety guidelines.

TESAMORELIN
(10MG)

SHOP VIALS

SHOP PRE-FILLED PEN

HIGHLIGHTS

Tesamorelin is a synthetic analogue of the Growth Hormone-Releasing Hormone (GHRH). It is a stabilized 44-amino acid peptide that acts specifically on the pituitary gland to stimulate the natural, pulsatile secretion of endogenous Growth Hormone (GH). In research models, Tesamorelin is highly regarded for its unique ability to target and reduce visceral adipose tissue (VAT) without significantly impacting subcutaneous fat or glucose metabolism. Unlike direct GH administration, Tesamorelin preserves the natural feedback loop of the HPA axis, making it a primary focus for studies involving metabolic syndrome, lipodystrophy, and age-related GH decline.

Observed Benefits

Selective Visceral Fat Reduction: Specifically studied for its potent ability to reduce deep abdominal (visceral) fat.
IGF-1 Modulation: Effectively raises systemic IGF-1 levels, supporting cellular repair and muscle protein synthesis.
Metabolic Health: Observed to improve lipid profiles and waist-to-hip ratios in research subjects.
Cognitive Support: Emerging research explores its impact on cognitive function and executive tasks in aging populations.
Preserved Natural Pulse: Stimulates endogenous GH production, minimizing the risk of "GH bleed" or pituitary shutdown.

Protocol Overview

Research involving Tesamorelin utilizes daily subcutaneous administration, typically performed in a fasted state to maximize pituitary response. To ensure standardized and accurate results in South African laboratory environments, each 10mg vial is reconstituted with 3.0 mL of Bacteriostatic Water. This creates a concentration of approximately 3.33 mg (3333 mcg) per mL.

Research Protocol Dosing

Concentration Reference:

10mg Vial + 3.0 mL: ~3.33 mg per mL (1 unit = ~33.3 mcg).

The following measurements provide the required units on a U-100 insulin syringe for a daily research schedule. Tesamorelin is typically administered 5 to 7 days per week.

Phase 1: Initial Assessment (500 mcg Daily)

Measurement: 15 units on a U-100 syringe.
Purpose: To observe initial pituitary sensitivity and baseline IGF-1 response.

Phase 2: Standard Research Dose (1,000 mcg / 1 mg Daily)

Measurement: 30 units on a U-100 syringe.
Purpose: The most common dose studied for metabolic regulation and visceral fat reduction

Phase 3: High-Intensity Research (2,000 mcg / 2 mg Daily)

Measurement: 60 units on a U-100 syringe.
Purpose: Studied in clinical trials for maximum efficacy in treating severe lipodystrophy.

Frequency: Administration is best conducted once daily, ideally in the evening or immediately upon waking, at least 90 minutes away from food.

Supplies Needed

Biolabs Peptides Tesamorelin: 10mg Lyophilized Vial.
Reconstitution Liquid: 3.0 mL of Bacteriostatic Water.
Syringes: U-100 Precision Insulin Syringes (0.5 mL or 1.0 mL recommended).
Prep: Sterile alcohol swabs for vial and site sterilization.

Storage

Pre-reconstitution (Lyophilized Powder): Store frozen at -20°C (-4°F) for long-term stability (up to 24 months). Protect from UV light.
Post-reconstitution (Liquid Solution): Must be kept refrigerated at 2–8°C (36–46°F). Once mixed, the solution should be used within 14–21 days for peak bioactivity.
Handling: Tesamorelin is a large, fragile peptide. Do not shake the vial. Gently roll or swirl until the powder is fully dissolved and the solution is clear.